SP
RDY icon

Sarasin & Partners’s Dr. Reddy's Laboratories RDY Stock Holding History

Sarasin & Partners’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-293,790
Closed -$2.22M – 145
2013
Q3 		$2.22M Sell
293,790
-5,175
-2% -$37.6K 0.03% 118
2013
Q2 		$2.26M Buy
+298,965
New +$2.18M 0.03% 123

Other funds holding RDY

CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $91.8B AUM 38.24% 1-Year Est. Return

Sarasin & Partners's RDY Position: Q4 2013 in Review

Sarasin & Partners sold out of Dr. Reddy's Laboratories (RDY) in Q4 2013, closing a stake of 293,790 shares — an estimated $2.22M sold.

Sarasin & Partners first reported a position in RDY in Q2 2013 and held it in 2 quarters. The position peaked at $2.26M in Q2 2013. 149 funds tracked by Wall St. Rank hold RDY as of Q4 2013.

  • Sarasin & Partners reported no remaining Dr. Reddy's Laboratories position as of Q4 2013 after selling out during the quarter.
  • Sarasin & Partners sold 293,790 Dr. Reddy's Laboratories shares in Q4 2013, an estimated $2.22M.
  • Sarasin & Partners first reported a position in Dr. Reddy's Laboratories in Q2 2013 and held it in 2 quarters.
  • Sarasin & Partners's Dr. Reddy's Laboratories position peaked at $2.26M in Q2 2013.
  • 149 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2013.

Based on Sarasin & Partners's 13F filing for Q4 2013, filed 13 Feb 2014.